Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Browsing Tag

ophthalmology

9 posts
RRoche
Roche’s Susvimo Gets EU Approval Recommendation for nAMD
Read More

Roche’s Susvimo Gets EU Approval Recommendation for nAMD

  • 2026-07-24
Roche (OTCQX: RHHBY) announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP)…
RRoche
Eye disease biotech launches with $100M, Roche rival in clinic
Read More

Eye disease biotech launches with $100M, Roche rival in clinic

  • 2026-06-11
During his tenure at Roche’s Genentech, ophthalmologist Jason Ehrlich, M.D., Ph.D., supported the development of the blockbuster eye…
RRoche
Data show Roche’s sixth-generation Troponin T test offers a new level of accuracy critical for diagnosing heart attacks
Read More

Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026

  • 2026-05-05
F. Hoffmann-La Roche Ltd New real-world data confirm Vabysmo’s potent retinal drying in nAMD and DME Key data…
RRoche
Roche announces positive phase III results for Gazyva/Gazyvaro in primary membranous nephropathy, marking a significant milestone in this autoimmune disease
Read More

Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026

  • 2026-05-04
F. Hoffmann-La Roche Ltd New real-world data confirm Vabysmo’s potent retinal drying in nAMD and DME Key data…
RRoche
Data show Roche’s sixth-generation Troponin T test offers a new level of accuracy critical for diagnosing heart attacks
Read More

Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026

  • 2026-05-03
F. Hoffmann-La Roche Ltd New real-world data confirm Vabysmo’s potent retinal drying in nAMD and DME Key data…
RRoche
Genentech persevERA breast cancer trial misses PFS goal
Read More

Genentech brings 45 ophthalmology abstracts to ARVO 2026

  • 2026-04-30
04/30/2026 –…
RRoche
Genentech persevERA breast cancer trial misses PFS goal
Read More

Roche to present 45 ophthalmology studies at ARVO

  • 2026-04-30
Roche (OTCQX: RHHBY) will present more than 45 abstracts at ARVO 2026 (3–7…
SSwitzerland
Outlook Therapeutics, Mediconsult in Swiss LYTENAVA pact
Read More

Outlook Therapeutics, Mediconsult in Swiss LYTENAVA pact

  • 2026-02-19
Outlook Therapeutics (Nasdaq: OTLK) signed an exclusive commercial distribution agreement with Mediconsult AG…
RRoche
Roche fenebrutinib Phase III hits PPMS disability goal
Read More

Roche’s Contivue Earns CE Mark for Continuous Eye Disease Treatment

  • 2026-02-17
Roche (OTCQX:RHHBY) has received CE mark approval for Contivue, its Port Delivery Platform…
Switzerland
www.europesays.com